CMS Grants National Coverage Determination for Cologuard
CMS has agreed to provide reimbursement coverage for Exact Sciences’ first-mover FDA-approved noninvasive stool DNA screening test for colorectal cancer.
Read MorePosted by Steve Halasey | Oct 20, 2014 | Cancer, Unknown Origin & Other Cancer Types |
CMS has agreed to provide reimbursement coverage for Exact Sciences’ first-mover FDA-approved noninvasive stool DNA screening test for colorectal cancer.
Read MorePosted by Steve Halasey | Oct 8, 2014 | Uncategorized |
At the ASCP annual meeting, a panel of healthcare experts will focus on changes in the regulatory, compliance, and billing environment for pathology professionals.
Read MorePosted by Steve Halasey | Sep 29, 2014 | Molecular Diagnostics |
Thermo Fisher Scientific has completed FDA listing of its Ion PGM Dx next-generation sequencing system as Class II medical device.
Read MorePosted by Jenny Lower | Sep 22, 2014 | Information Technology, Labware Washers |
Liquid Handling Control software from BioTek enables any LHC-enabled washer or dispenser to be integrated into a robotic system that complies with the universal methods for microplate washers and dispensers published by the Consortium for Standardization in Lab Automation.
Read MorePosted by Steve Halasey | Sep 22, 2014 | Research |
A study demonstrates that use of a molecular test by bioTheranostics results in cost savings for ER+ breast cancer patients by optimizing initial chemotherapy and extended endocrine therapy after 5 years.
Read More